Supplementary Figure 2 - UPA 45
Published: 25 December 2025| Version 1 | DOI: 10.17632/mx2kbrdb5v.1
Contributor:
Joan CeravallsDescription
Mean NRS-pruritus and DLQI evolution following upadacitinib 45mg intensification.
Files
Categories
Dermatology